Athersys
ATHX
#11267
Rank
โ‚ฌ0.75 M
Marketcap
0,01222ย โ‚ฌ
Share price
-33.50%
Change (1 day)
-98.84%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -โ‚ฌ38.74 Million

According to Athersys's latest financial reports the company's current earnings are โ‚ฌ0.08 Million. In 2022 the company made an earning of -โ‚ฌ69.7 Million, an increase over its 2021 earnings that were of -โ‚ฌ78.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -โ‚ฌ38.74 Million-44.42%
2022 -โ‚ฌ69.7 Million-11.54%
2021 -โ‚ฌ78.79 Million11.14%
2020 -โ‚ฌ70.89 Million72.2%
2019 -โ‚ฌ41.17 Million77.29%
2018 -โ‚ฌ23.22 Million-22.91%
2017 -โ‚ฌ30.12 Million111.89%
2016 -โ‚ฌ14.22 Million-8.52%
2015 -โ‚ฌ15.54 Million-40.81%
2014 -โ‚ฌ26.26 Million18.62%
2013 -โ‚ฌ22.14 Million
2011 -โ‚ฌ12.48 Million19.71%
2010 -โ‚ฌ10.42 Million-26.28%
2009 -โ‚ฌ14.14 Million-18.21%
2008 -โ‚ฌ17.28 Million-8.28%
2007 -โ‚ฌ18.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ16.94 B-44,927.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ6.30 B-16,785.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ10.00 B-26,564.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ7.04 B-18,748.60%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚ฌ6.08 B-16,198.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ10.25 B-27,234.72%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
โ‚ฌ0.15 B-512.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-โ‚ฌ2.76 Billion 7,191.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-โ‚ฌ0.57 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA